Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.
Authors
Ryan H. Moy
Columbia University, New York, NY;
Ryan H. Moy , Sharon Wu , Joanne Xiu , Phillip Walker , Wolfgang Michael Korn , Emil Lou , Anthony Frank Shields , Sanjay Goel , Anwaar Saeed , Adam Joel Bass
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 440)
DOI
10.1200/JCO.2023.41.4_suppl.440
Abstract #
440
Poster Bd #
K6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
First Author: Tanya Jindal
Poster
2021 ASCO Annual Meeting
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
First Author: Tenley Klc
Poster
2020 Gastrointestinal Cancers Symposium
Molecular characterization of appendiceal goblet cell carcinoid.
First Author: Hiroyuki Arai
Poster
2019 ASCO Annual Meeting
Molecular comparison between peritoneal metastases (PM) and primary gastric (GC) and gastroesophageal junction (GEJ) cancer.
First Author: Matthew K Stein